Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ljiljana Balint-Peric"'
Autor:
Ljiljana Balint-Peric, Jagoda Nikolić, Danijela Tatović-Babić, Teodora Beljic, Milka Drezgić, Darko Babić, Draginja Trpković
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 130, Iss 11-12, Pp 371-375 (2002)
Postmenopause and smoking impair lipid profile, induce hypercoagulability and reduce fibrinolytic capacity [1, 2]. Postmenopause induced lipid changes can be reversed by oestrogen replacement [3]. Oestrogens also reduce fibrino-gen level [4] and have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0492912389a14a0fdffb0ae4d14c46a2
https://doi.org/10.2298/sarh0212371t
https://doi.org/10.2298/sarh0212371t
Publikováno v:
Maturitas. 28:271-276
Objective: Postmenopausal women with non-insulin dependent diabetes (NIDDM) are frequently obese, hypertensive and hyperlipidaemic and hence at particular risk of coronary heart disease (CHD). They might therefore benefit from menopausal therapy. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c884364c096361c860881595370b4a5f
https://doi.org/10.1016/s0378-5122(97)00074-1
https://doi.org/10.1016/s0378-5122(97)00074-1
Publikováno v:
Clinical Endocrinology. 43:677-681
Summary OBJECTIVE Women with the polycystic ovary syndrome (PCOS) often have several of the known risk factors for cardiovascular disease, including hyperinsulinaemia. We have therefore investigated variables of cardiac flow in young women with PCOS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab4b219451c782b1f89de749a4009cee
https://doi.org/10.1111/j.1365-2265.1995.tb00534.x
https://doi.org/10.1111/j.1365-2265.1995.tb00534.x
Autor:
Paul J. Hardiman, H. Orskov, S. Okolo, Ljiljana Balint-Peric, Gordana M. Prelevic, Jean Ginsburg, Michael B. Thomas, D. Maletic
Publikováno v:
Human Reproduction. 10:28-32
The elevated luteinizing hormone (LH) and androgen concentrations characteristic of women with polycystic ovaries (PCO) are considered crucial factors in their infertility. The somatostatin analogue octreotide lowers LH and androgen concentrations in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbcd0a52d3fc1a1e8956b81fa136bd92
https://doi.org/10.1093/humrep/10.1.28
https://doi.org/10.1093/humrep/10.1.28
Publikováno v:
Annals of the New York Academy of Sciences. 687:255-262
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::974566e202881a5a6a868f3388ee596d
https://doi.org/10.1111/j.1749-6632.1993.tb43874.x
https://doi.org/10.1111/j.1749-6632.1993.tb43874.x
Publikováno v:
Annals of the New York Academy of Sciences. 592:463-465
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f817907799676241b23996bd6dd4c83
https://doi.org/10.1111/j.1749-6632.1990.tb30375.x
https://doi.org/10.1111/j.1749-6632.1990.tb30375.x
Autor:
Ljiljana Balint-Peric, M.I. Wurzburger, Gordana M. Prelevic, Paul J. Hardiman, S. Okolo, Jean Ginsburg, D. Maletic
Publikováno v:
Metabolism: clinical and experimental. 41(9 Suppl 2)
In view of the association of hyperinsulinemia with elevated luteinizing hormone (LH) levels and hyperandrogenism in polycystic ovary syndrome (PCOS), the effect of octreotide was investigated in women with PCOS. Twelve amenorrheic women were treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88a1e2d36e7cc765b8b6e7497c30407f
https://pubmed.ncbi.nlm.nih.gov/1518438
https://pubmed.ncbi.nlm.nih.gov/1518438